STOCK MARKET BSE NSE
Home Videos Nation

Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet in India

Published: 25th July 2020 02:29 PM  |   Last Updated: 25th July 2020 02:30 PM  

Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.

Now we are on Telegram too. Follow us for updates
TAGS
Jenburkt Pharma
India Matters
RJD supremo Lalu Prasad Yadav (Photo | PTI)
CBI registers fresh case against Lalu Prasad Yadav, searches 16 locations
Representational Image. (File Photo)
Pegasus: SC extends time for submitting probe report on use of Israeli spyware 
Sugarcane farmers are not able to sell their yield in Tirunelveli. (Photo | V Karthikalagu, EPS)
Over 17 lakh tonnes of sugarcane still lying in farms across Maha despite end of crushing season 
Jawaharlal Nehru campus. (File Photo | EPS)
Reducing India to civic nation bound by Constitution disregards its history, civilisation: JNU VC 

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp